{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:16:01Z","timestamp":1760955361380},"reference-count":73,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1097\/mot.0b013e3283592684","type":"journal-article","created":{"date-parts":[[2012,10,5]],"date-time":"2012-10-05T07:57:02Z","timestamp":1349423822000},"page":"586-593","source":"Crossref","is-referenced-by-count":19,"title":["Update in HIV infection in organ transplantation"],"prefix":"10.1097","volume":"17","author":[{"given":"Paolo A.","family":"Grossi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-3-20211004","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/QAI.0b013e3181e9be6b","article-title":"; EuroSIDA Study Group. Serious fatal and nonfatal non-AIDS-defining illnesses in Europe.","volume":"55","author":"Mocroft","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R3-3-20211004","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/s-0032-1316472","article-title":"Liver toxicity of antiretroviral drugs.","volume":"32","author":"Jones","year":"2012","journal-title":"Semin Liver Dis"},{"key":"R4-3-20211004","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1055\/s-0032-1316471","article-title":"Nonalcoholic fatty liver disease and HIV infection.","volume":"32","author":"Vallet-Pichard","year":"2012","journal-title":"Semin Liver Dis"},{"key":"R5-3-20211004","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1055\/s-0032-1316473","article-title":"The burden of liver disease in human immunodeficiency virus-infected patients.","volume":"32","author":"Puoti","year":"2012","journal-title":"Semin Liver Dis"},{"key":"R6-3-20211004","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1182\/blood.V93.3.1113","article-title":"Liver transplantation in a hemophilia patient with acquired immunodeficiency syndrome.","volume":"93","author":"Ragni","year":"1999","journal-title":"Blood"},{"key":"R7-3-20211004","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1600-6143.2007.02061.x","article-title":"HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes.","volume":"8","author":"Roland","year":"2008","journal-title":"Am J Transplant"},{"key":"R8-3-20211004","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/QAD.0b013e328344febb","article-title":"Liver transplant outcomes in HIV-infected patients: a systematic review and meta-analysis with synthetic cohort.","volume":"25","author":"Cooper","year":"2011","journal-title":"AIDS"},{"key":"R9-3-20211004","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-0032-1316474","article-title":"Liver transplantation in HIV patients.","volume":"32","author":"Fox","year":"2012","journal-title":"Semin Liver Dis"},{"key":"R11-3-20211004","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/lt.20534","article-title":"Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease.","volume":"11","author":"Ragni","year":"2005","journal-title":"Liver Transpl"},{"key":"R12-3-20211004","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/lt.21735","article-title":"ESLD-HIV Working Group InvestigatorsThe Model For End-Stage Liver Disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.","volume":"15","author":"Murillas","year":"2009","journal-title":"Liver Transpl"},{"key":"R13-3-20211004","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1053\/j.gastro.2009.09.053","article-title":"MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates.","volume":"138","author":"Subramanian","year":"2010","journal-title":"Gastroenterology"},{"key":"R14-3-20211004","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1086\/379254","article-title":"Survival of human immunodeficiency virus-infected liver transplant recipients.","volume":"188","author":"Ragni","year":"2003","journal-title":"J Infect Dis"},{"key":"R15-3-20211004","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1111\/j.1600-6143.2006.01546.x","article-title":"Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C.","volume":"6","author":"de Vera","year":"2006","journal-title":"Am J Transplant"},{"key":"R16-3-20211004","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/hep.21990","article-title":"Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus.","volume":"47","author":"Duclos-Vallee","year":"2008","journal-title":"Hepatology"},{"key":"R17-3-20211004","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/TP.0b013e3181605fda","article-title":"Impact of human immunodeficiency virus on survival after liver transplantation: analysis of United Network for Organ Sharing database.","volume":"85","author":"Mindikoglu","year":"2008","journal-title":"Transplantation"},{"key":"R18-3-20211004","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/j.1600-6143.2011.03608.x","article-title":"Fibrosing cholestatic hepatitis in HIVHCV co-infected transplant patients-usefulness of early markers after liver transplantation.","volume":"11","author":"Antonini","year":"2011","journal-title":"Am J Transplant"},{"key":"R19-3-20211004","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/lt.23411","article-title":"for the Solid Organ Transplantation in HIV: Multi-Site Study InvestigatorsOutcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection.","volume":"18","author":"Terrault","year":"2012","journal-title":"Liver Transpl"},{"key":"R20-3-20211004","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1600-6143.2012.04028.x","article-title":"the Spanish OLT in HIV-Infected Patients Working Group InvestigatorsOutcome of HCVHIV-coinfected liver transplant recipients: a prospective and multicenter cohort study.","volume":"12","author":"Miro","year":"2012","journal-title":"Am J Transplant"},{"key":"R21-3-20211004","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/lt.22431","article-title":"OLT-HIV FIPSE Cohort InvestigatorsEpidemiology and outcome of infections in human immunodeficiency virushepatitis C virus-coinfected liver transplant recipients: a FIPSEGESIDA prospective cohort study.","volume":"18","author":"Moreno","year":"2012","journal-title":"Liver Transpl"},{"key":"R24-3-20211004","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11904-012-0125-9","article-title":"Renal dysfunction in the setting of HIVAIDS.","volume":"9","author":"Miro","year":"2012","journal-title":"Curr HIVAIDS Rep"},{"key":"R25-3-20211004","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1525-139X.2005.18108.x","article-title":"National surveillance of dialysis-associated diseases in the United States, 2002.","volume":"18","author":"Finelli","year":"2005","journal-title":"Semin Dial"},{"key":"R26-3-20211004","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/j.1523-1755.2005.00229.x","article-title":"The clinical characteristics of HIV-infected patients receiving dialysis in France between 1997 and 2002.","volume":"67","author":"Vigneau","year":"2005","journal-title":"Kidney Int"},{"key":"R27-3-20211004","first-page":"1229","article-title":"the Spanish HIV Infection in Dialysis Study GroupPrevalence and clinical characteristics of HIV type 1-infected patients receiving dialysis in Spain: results of a Spanish survey in 2006 - GESIDA 4805 study.","volume":"24","author":"Trullas","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R28-3-20211004","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/QAI.0b013e318221fbda","article-title":"Spanish HIV Infection in Dialysis Study GroupOutcome and prognostic factors in HIV-1-infected patients on dialysis in the cART era: a GESIDASEN cohort study.","volume":"57","author":"Trullas","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R29-3-20211004","first-page":"1082","article-title":"Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med 2010; 363:2004-2014.","volume":"364","author":"Stock","year":"2011","journal-title":"Erratum in: N Engl J Med"},{"key":"R30-3-20211004","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/ki.2010.545","article-title":"Renal transplantation in HIV-infected patients: 2010 update.","volume":"79","author":"Trullas","year":"2011","journal-title":"Kidney Int"},{"key":"R31-3-20211004","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/j.1523-1755.2005.00245.x","article-title":"Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients.","volume":"67","author":"Kumar","year":"2005","journal-title":"Kidney Int"},{"key":"R32-3-20211004","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1111\/j.1600-6143.2010.03258.x","article-title":"Renal transplantation in HIV-infected patients: the Paris experience.","volume":"10","author":"Touzot","year":"2010","journal-title":"Am J Transplant"},{"key":"R33-3-20211004","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMc0900837","article-title":"Renal transplantation between HIV-positive donors and recipients.","volume":"362","author":"Muller","year":"2010","journal-title":"N Engl J Med"},{"key":"R34-3-20211004","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2165\/00003495-200868070-00006","article-title":"Renal disease in patients with HIV infection: epidemiology, pathogenesis and management.","volume":"68","author":"Fine","year":"2008","journal-title":"Drugs"},{"key":"R35-3-20211004","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/MOT.0b013e328341b0b5","article-title":"Long-term outcomes after simultaneous pancreas-kidney transplant.","volume":"16","author":"Wai","year":"2011","journal-title":"Curr Opin Organ Transplant"},{"key":"R36-3-20211004","first-page":"56","article-title":"Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR).","volume":"45-","author":"Gruessner","year":"2008","journal-title":"Clin Transpl"},{"key":"R37-3-20211004","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1034\/j.1600-6143.2003.00119.x","article-title":"Pancreas-kidney transplantation in a long-term nonprogressor HIV-infected recipient.","volume":"3","author":"Toso","year":"2003","journal-title":"Am J Transplant"},{"key":"R38-3-20211004","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1016\/j.transproceed.2010.09.003","article-title":"Simultaneous pancreas-kidney transplantation in HIV-infected patients: a case report and literature review.","volume":"42","author":"Miro","year":"2010","journal-title":"Transplant Proc"},{"key":"R39-3-20211004","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1016\/j.transproceed.2011.08.093","article-title":"Simultaneous pancreas kidney transplantation in the HIV-positive patient.","volume":"43","author":"Akhtar","year":"2011","journal-title":"Transplant Proc"},{"key":"R40-3-20211004","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/j.1600-6143.2011.03906.x","article-title":"Report of four simultaneous pancreas-kidney transplants in HIV-positive recipients with favorable outcomes.","volume":"12","author":"Grossi","year":"2012","journal-title":"Am J Transplant"},{"key":"R41-3-20211004","first-page":"127","article-title":"Prevalence of cholecystolithiasis and its management among kidneypancreas-transplanted type 1 (insulin-dependent) diabetic patients.","volume":"13","author":"Schiemann","year":"2008","journal-title":"Eur J Med Res"},{"key":"R42-3-20211004","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11908-003-0096-5","article-title":"Cardiovascular complications in patients with HIV infection.","volume":"5","author":"Zareba","year":"2003","journal-title":"Curr Infect Dis Rep"},{"key":"R43-3-20211004","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/archinte.160.5.602","article-title":"Cardiac manifestations of acquired immunodeficiency syndrome.","volume":"160","author":"Rerkpattanapipat","year":"2000","journal-title":"Arch Intern Med"},{"key":"R44-3-20211004","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/QAI.0b013e31818ceaa4","article-title":"Cardiovascular complications in HIV management: past, present, and future.","volume":"50","author":"Aberg","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R45-3-20211004","first-page":"98","article-title":"Update on cardiovascular complications in HIV infection.","volume":"17","author":"Currier","year":"2009","journal-title":"Top HIV Med"},{"key":"R46-3-20211004","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1086\/649897","article-title":"Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.","volume":"201","author":"Worm","year":"2010","journal-title":"J Infect Dis"},{"key":"R47-3-20211004","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00007890-199002000-00025","article-title":"Transplantation in HIV patients.","volume":"49","author":"Tzakis","year":"1990","journal-title":"Transplantation"},{"key":"R48-3-20211004","first-page":"611","article-title":"HIV infection after heart transplantation: a case report.","volume":"10","author":"Anthuber","year":"1991","journal-title":"J Heart Lung Transplant"},{"key":"R49-3-20211004","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1699-0463.1998.tb01373.x","article-title":"HIV infection in the first heart transplantation in Italy: fatal outcome. Case report.","volume":"106","author":"Calabrese","year":"1998","journal-title":"APMIS"},{"key":"R50-3-20211004","first-page":"306","article-title":"Human immunodeficiency virus infection transmitted from an organ donor screened for HIV antibody: North Carolina.","volume":"36","year":"1987","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R51-3-20211004","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1201-9712(97)90011-4","article-title":"Human immunodeficiency virus infection after heart transplantation: development of cardiomyopathy after long term survival.","volume":"2","author":"Tambini","year":"1997","journal-title":"Int J Infect Dis"},{"key":"R52-3-20211004","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/lt.21534","article-title":"Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation.","volume":"14","author":"Ahn","year":"2008","journal-title":"Liver Transplant"},{"key":"R53-3-20211004","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1600-6143.2008.02154.x","article-title":"Long-term follow-up of a heart transplant recipient with documented seroconversion to HIV-positive status 1 year after transplant.","volume":"8","author":"Gupta","year":"2008","journal-title":"Am J Transplant"},{"key":"R54-3-20211004","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1600-6143.2011.03597.x","article-title":"HIV-HCV Transplantation Transmission Investigation TeamTransmission of human immunodeficiency virus and hepatitis C virus from an organ donor to four transplant recipients.","volume":"11","author":"Ison","year":"2011","journal-title":"Am J Transplant"},{"key":"R55-3-20211004","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1056\/NEJMoa022935","article-title":"Successful cardiac transplantation in an HIV-1-infected patient with advanced disease.","volume":"348","author":"Calabrese","year":"2003","journal-title":"N Engl J Med"},{"key":"R56-3-20211004","first-page":"1639","article-title":"Should HIV-positive recipients undergo heart transplantation J Thorac Cardiovasc S","volume":"126","author":"Bisleri","year":"2003","journal-title":"urg"},{"key":"R57-3-20211004","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.healun.2009.04.005","article-title":"Heart transplantation in human immunodeficiency virus-positive patients.","volume":"28","author":"Uriel","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"R58-3-20211004","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.healun.2011.02.003","article-title":"A European first: successful heart transplant in a human immunodeficiency virus-positive recipient.","volume":"30","author":"Durante-Mangoni","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R59-3-20211004","first-page":"968","article-title":"High-urgency priority heart transplantation in HIV-positive patients on life support: breaking barriers J Heart Lung T","volume":"30","author":"Boignard","year":"2011","journal-title":"ransplant"},{"key":"R60-3-20211004","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.recesp.2010.12.007","article-title":"Heart transplantation in an HIV-1-infected patient with ischemic cardiomyopathy and severe pulmonary hypertension.","volume":"64","author":"Castel","year":"2011","journal-title":"Rev Esp Cardiol"},{"key":"R61-3-20211004","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.healun.2011.07.022","article-title":"Heart transplantation in HIV-infected patients: more cases in Europe.","volume":"30","author":"Castel","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R62-3-20211004","first-page":"82","article-title":"Review of transplantation in HIV patients during the HAART era.","volume":"63-","author":"Pelletier","year":"2004","journal-title":"Clin Transpl"},{"key":"R63-3-20211004","first-page":"228","article-title":"Fulminant myocarditis during HIV seroconversion: recovery with temporary left ventricular mechanical assistance.","volume":"5","author":"Brucato","year":"2004","journal-title":"Ital Heart J"},{"key":"R64-3-20211004","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1510\/icvts.2009.215244","article-title":"Left ventricular assist device placement in a patient with end-stage heart failure and human immunodeficiency virus.","volume":"9","author":"Fieno","year":"2009","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"R65-3-20211004","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1510\/icvts.2009.212076","article-title":"Heartmate XVE destination therapy for end-stage heart failure in a patient with human immunodeficiency virus.","volume":"9","author":"Mehmood","year":"2009","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"R66-3-20211004","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.healun.2011.03.004","article-title":"Human immunodeficiency virus infection and left ventricular assist devices: a case series.","volume":"30","author":"Sims","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R67-3-20211004","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0046-8177(87)80417-3","article-title":"Membranoproliferative glomerulonephritis and plexogenic pulmonary arteriopathy in a homosexual man with acquired immunodeficiency syndrome.","volume":"18","author":"Kim","year":"1987","journal-title":"Hum Pathol"},{"key":"R68-3-20211004","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1378\/chest.118.4.1133","article-title":"HIV-related pulmonary hypertension: analytic review of 131 cases.","volume":"118","author":"Mehta","year":"2000","journal-title":"Chest"},{"key":"R69-3-20211004","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: results from a national registry.","volume":"173","author":"Humbert","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"R70-3-20211004","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1097\/01.aids.0000247569.03504.8b","article-title":"Pulmonary hypertension in individuals with HIV infection.","volume":"20","author":"Petrosillo","year":"2006","journal-title":"AIDS"},{"key":"R71-3-20211004","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1111\/j.1600-6143.2009.02779.x","article-title":"Successful lung transplantation in an HIV- and HBV-positive patient with cystic fibrosis.","volume":"9","author":"Bertani","year":"2009","journal-title":"Am J Transplant"},{"key":"R72-3-20211004","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/j.1600-6143.2007.02007.x","article-title":"Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients.","volume":"7","author":"Frassetto","year":"2007","journal-title":"Am J Transplant"},{"key":"R74-3-20211004","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1111\/j.1600-6143.2009.02684.x","article-title":"Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs.","volume":"9","author":"Tricot","year":"2009","journal-title":"Am J Transplant"},{"key":"R75-3-20211004","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/S0140-6736(00)04898-4","article-title":"CC chemokine receptor 5 and renal transplant survival.","volume":"357","author":"Fischereder","year":"2001","journal-title":"Lancet"},{"key":"R76-3-20211004","first-page":"36","article-title":"Chemokine receptor 5 Delta32 mutation reduces the risk of acute rejection in liver transplantation.","volume":"14","author":"Heidenhain","year":"2009","journal-title":"Ann Transplant"},{"key":"R77-3-20211004","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa1201248","article-title":"Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease.","volume":"367","author":"Reshef","year":"2012","journal-title":"N Engl J Med"},{"key":"R78-3-20211004","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.25653","article-title":"Review and management of drug interactions with boceprevir and telaprevir.","volume":"55","author":"Kiser","year":"2012","journal-title":"Hepatology"}],"container-title":["Current Opinion in Organ Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00075200-201212000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T06:21:32Z","timestamp":1633501292000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00075200-201212000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":73,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mot.0b013e3283592684","relation":{},"ISSN":["1087-2418"],"issn-type":[{"value":"1087-2418","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}